Anthropic’s planned IPO is more than a test of demand for the company behind Claude. At the top of its proposed price range, the share sale could raise about $64.4 billion; combined with a separately reported private placement, the package could total $90.4 billion. The figures are conditional, and the offering has not yet been completed.
7
46
The proposed deal: 825 million shares at $70–$78
Anthropic launched its IPO roadshow on November 10. The proposed sale covers 825 million Class A shares, with 801,351,354 offered by Anthropic and 23,648,646 by existing shareholders. The proposed price range is $70 to $78 per share, and the company intends to list on Nasdaq under the ticker ANT.
36
7
At those prices, the total offering represents roughly $57.75 billion to $64.35 billion before underwriting discounts. Because some shares are being sold by existing holders, the headline offering value is not all new capital for Anthropic.
7
36
Reports say the company also plans a separate $26 billion private placement. On that basis, the IPO and placement could together reach $90.4 billion if the public offering prices at the high end of its range. That combined figure is not the IPO proceeds alone. Reports also describe a possible total above $100 billion if underwriters exercise an over-allotment option; that, too, is conditional.
30
46
The reported timetable calls for pricing on November 18 and Nasdaq trading on November 19, subject to regulatory clearance and any changes to the offering.
9
52
A proposed valuation below earlier speculation
The proposed price range implies a fully diluted valuation of up to roughly $1.4 trillion, according to Reuters.
46 Earlier reports discussed valuations as high as $2 trillion, while later coverage put the proposed range lower.
26 Those figures may use different assumptions, so they should not be treated as directly comparable. The proposed range, rather than earlier speculation, is the more relevant measure of the deal currently being marketed.
The valuation makes the IPO a high-profile test of investor appetite for AI companies. It does not, on its own, establish what the company will be worth once trading begins or whether public investors will sustain that valuation.
Why it matters for US equity fundraising
The possible scale of Anthropic’s financing sits within a broader year of large equity transactions. Bloomberg-compiled figures reported that US-listed companies had raised more than $425 billion in 2026 across IPOs, completed at-the-market programs and marketed share sales.
30 That total includes several types of fundraising, so it should not be read as IPO proceeds alone.
The proposed $90.4 billion package would exceed the reported $86.2 billion raised in SpaceX’s June listing—but this comparison combines Anthropic’s planned IPO with a private placement, rather than comparing two IPOs on identical terms.
30 The scale is striking; the deal structures matter when interpreting the record claim.
A very large offering could show that public markets are willing to finance AI companies at a scale previously associated with the biggest corporate transactions. But one proposed deal cannot establish that this level of fundraising will become typical, or that the capital will be available to smaller AI companies.
Claude’s growth—and the investor questions behind it
Anthropic is the developer of Claude. Reuters reported that revenue grew 1,368% year over year in the three months ended June 30, while the company warned in its prospectus that growth could slow or fluctuate.
47 A separate IPO preview reports $33.2 billion in revenue for the first nine months of 2026, compared with $2.5 billion a year earlier; another report gives an $81 billion annualized revenue run rate by October.
4
53
Those measures are not interchangeable. Revenue over nine months is a period total; an annualized run rate extrapolates a pace of activity and is not the same as revenue already earned over a full year. Investors will also weigh growth against the costs and risks described in Anthropic’s prospectus and public reporting.
47
What remains uncertain
Investor demand reports should be treated cautiously. Coverage described the IPO as multiple times oversubscribed, citing reported indications of interest, but that does not guarantee the final price, completed fundraising or strong trading after the listing.
28 The roadshow and proposed terms show what Anthropic is seeking; final results will show what investors actually commit.
The broader market backdrop is another consideration. Reuters reported on November 5 that some potential investors questioned the timing and valuation of the IPO.
45 A later report described Anthropic pressing ahead amid a sell-off in AI-related stocks.
20 These reports underline why the proposed timetable and price should not be mistaken for a settled outcome.
For founders and venture investors, the useful signal is not simply that a giant AI offering may come to market. It is whether investors accept the price, whether the financing is completed, and how the shares trade afterward. Until those questions are answered, Anthropic’s IPO is best understood as a high-stakes test of public-market appetite—not proof that comparable funding is available to every AI startup.